In 2018, survey data published in the journal Cannabis and Cannabinoid Research  shows Medical cannabis use is relatively common among patients with sickle cell disease for pain control.

Background: surveyed patients with a brief, anonymous, questionare. Reviewed institutional records for clinically driven urine drug testing. While we tracked patient requests for certification for medical marijuana.

You can Read the full article Here => https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6044416/